What’s new

Stay updated on the most recent developments in Symeres.

More news

Latest patents

  • Compounds and their use as PDE4 activators

    Number: WO/2024/038129

  • Compounds and their use as PDE4 activators

    Number: WO/2024/038128

  • Crystalline and liquid crystalline 25-hydroxy-cholest-5-en-3-sulfate sodium and methods for preparing same (Organix)

    Number: US 2023/0056273 A1

More patents

Latest publications

  • Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor

    Article: ChemMedChem 2024, e202300473

  • High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum

    Article: ACS Infect. Dis. 2024, XXXX, XXX, XXX-XXX

  • Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen

    Article: J. Med. Chem. 2024 (67), 3039-3065

More Publications

Feel free to contact us!

Curious to know more about what can we do for you? Get in touch and let’s start a conversation.

Contact us